(CURLF) – Analyst Previews Curaleaf Earnings: ‘Bellwether Of The U.S. Cannabis business’

Shares of U.S. cannabis that is multi-state Curaleaf Holdings Inc. (OTCQX: CURLF) traded lower by 3.6% on Thursday morning, but one analyst has high hopes for the company’s fourth-quarter earnings report next week.

The Analyst: on, Roth Capital Partners analyst Scott Fortune reiterated his Buy rating and $20 price target for Curaleaf.

Related thursday Link: 3 Reasons Cannabis shares might be Headed Lower The Thesis:

In their preview note, Fortune stated Curaleaf’s fourth-quarter earnings report is essential for the cannabis that is entire given the company is the “bellwether of the U.S. cannabis industry.”

“We believe the results will indicate the direction for the rest of the industry and are expecting a quarter that is relatively strong terms of income development, with integration nevertheless weighing on earnings,” Fortune said.

He stated objectives for the 4th quarter are high after Curaleaf’s impressive third-quarter figures, which demonstrated the effectiveness of Curaleaf’s aggressive strategy of licensing victories and purchases. Looking forward to 2021, Fortune stated Arizona and nj-new jersey will likely be growth that is key for Curaleaf. Once the company has fully integrated Grassroots and its other major acquisitions, Fortune said investors should expect an inflection in Curaleaf’s profitability.

Roth is calling for a fourth-quarter EPS loss of 2 cents, down slightly from a 1-cent loss in the quarter that is third. The company can be focusing on $239.5 million in revenue, up 31.3per cent…

Original Author Link click to learn story that is complete. Shares of U.S. multi-state cannabis operator Curaleaf Holdings Inc.

(OTCQX: CURLF) traded lower by 3.6% on Thursday morning, but one analyst has high hopes for the company’s fourth-quarter earnings report next week.The Analyst:

on, Roth Capital Partners analyst Scott Fortune reiterated his Buy rating and $20 price target for Curaleaf.Related thursday Link: 3 Reasons Cannabis shares might be Headed Lower

The Thesis:

In their preview note, Fortune stated Curaleaf’s fourth-quarter earnings report is essential for the cannabis that is entire given the company is the “bellwether of the U.S. cannabis industry.”

“We believe the results will indicate the direction for the rest of the industry and are expecting a quarter that is relatively strong terms of income development, with integration nevertheless weighing on earnings,” Fortune said.

He stated objectives for the 4th quarter are high after Curaleaf’s impressive third-quarter figures, which demonstrated the effectiveness of Curaleaf’s aggressive strategy of licensing victories and purchases. Looking forward to 2021, Fortune stated Arizona and nj-new jersey will likely be growth that is key for Curaleaf. Once the company has fully integrated Grassroots and its other major acquisitions, Fortune said investors should expect an inflection in Curaleaf’s profitability.

Roth is calling for a fourth-quarter EPS loss of 2 cents, down slightly from a 1-cent loss in the quarter that is third. The company can be focusing on $239.5 million in revenue, up 31.3per cent…(*)Source website link (*)

Latest posts